Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Vistagen Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +5 vs. Q2 2024
- Shares held
- 15.3M
- −674.7K (−4.2%) vs. Q2 2024
- Total value
- $45.3M
- −$9.60M (−17.5%) vs. Q2 2024
- New holders
- 8
- 9 more added
- Sold out
- 3
- 13 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 16 | $48 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 25 | $75 | 0.00% | −4,121−99.4% | Reduced |
| Fairman Group, LLC | 29 | $87 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 81 | $244 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 80 | $246 | 0.00% | 00.0% | Unchanged |
| SJS Investment Consulting Inc. | 100 | $301 | 0.00% | 00.0% | Unchanged |
| BFSG, LLC | 1,000 | $3.01K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,229 | $3.70K | 0.00% | +1,226+40,866.7% | Added |
| Bank of America Corp | 1,810 | $5.45K | 0.00% | +1,572+660.5% | Added |
| Tower Research Capital LLC (TRC) | 2,259 | $6.80K | 0.00% | −225−9.1% | Reduced |
| CWM, LLC | 2,416 | $7.00K | 0.00% | 00.0% | Unchanged |
| Caption Management, LLC | 4,460 | $13.4K | 0.00% | +4,460 | New |
| Royal Bank of Canada | 4,501 | $14.0K | 0.00% | +3,420+316.4% | Added |
| Morgan Stanley | 5,319 | $16.0K | 0.00% | −547−9.3% | Reduced |
| UBS Group AG | 10,121 | $30.5K | 0.00% | −9,145−47.5% | Reduced |
| Advisor Group Holdings, Inc. | 10,226 | $30.8K | 0.00% | −800−7.3% | Reduced |
| Jane Street Group, LLC | 19,659 | $59.2K | 0.00% | +19,659 | New |
| Kestra Advisory Services, LLC | 20,033 | $60.3K | 0.00% | +20,033 | New |
| Virtu Financial LLC | 20,210 | $61.0K | 0.00% | +4,722+30.5% | Added |
| HighTower Advisors, LLC | 20,828 | $64.0K | 0.00% | +20,828 | New |
| Simplex Trading, LLC | 23,000 | $69.0K | 0.00% | +5,893+34.4% | Added |
| Charles Schwab Investment Management Inc | 23,302 | $70.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 25,337 | $76.3K | 0.00% | +25,337 | New |
| Squarepoint Ops LLC | 27,575 | $83.0K | 0.00% | +16,180+142.0% | Added |
| American Century Companies Inc | 30,197 | $90.9K | 0.00% | −118−0.4% | Reduced |
| Valence8 US LP | 34,376 | $103.5K | 0.05% | +34,376 | New |
| Northern Trust Corp | 49,431 | $148.8K | 0.00% | −531−1.1% | Reduced |
| Susquehanna International Group, LLP | 52,094 | $156.8K | 0.00% | −13,013−20.0% | Reduced |
| Two Sigma Investments, LP | 61,542 | $185.2K | 0.00% | −5,969−8.8% | Reduced |
| AdvisorShares Investments LLC | 67,780 | $204.0K | 0.04% | +16,000+30.9% | Added |
| Blair William & Co | 88,466 | $266.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 88,708 | $267.0K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 150,000 | $451.5K | 0.27% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 163,078 | $490.9K | 0.08% | +163,078 | New |
| Goldman Sachs Group Inc | 176,261 | $530.5K | 0.00% | +1,279+0.7% | Added |
| Renaissance Technologies LLC | 190,600 | $573.7K | 0.00% | +125,700+193.7% | Added |
| Geode Capital Management, LLC | 258,524 | $778.4K | 0.00% | −31,570−10.9% | Reduced |
| Citadel Advisors LLC | 321,885 | $968.9K | 0.00% | −307,760−48.9% | Reduced |
| BlackRock, Inc. | 412,129 | $1.24M | 0.00% | +412,129 | New |
| Great Point Partners LLC | 674,075 | $2.03M | 0.61% | −855,263−55.9% | Reduced |
| Sphera Funds Management Ltd. | 808,550 | $2.43M | 0.40% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,517,696 | $4.57M | 0.38% | 00.0% | Unchanged |
| Commodore Capital LP | 1,575,000 | $4.74M | 0.30% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,846,792 | $4.90M | 1.47% | −1,790−0.1% | Reduced |
| Vanguard Group Inc | 1,793,166 | $5.40M | 0.00% | 00.0% | Unchanged |
| BVF Inc | 2,000,000 | $6.02M | 0.18% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,676,580 | $8.06M | 0.68% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −19,261−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −492−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |